Cancer is a shape-shifter. It doesn't stay the same. Neither do the genes that fuel it. One such gene, HER2, is well-known for its part in breast and stomach cancers. But it's not just limited to these. Around 3. 5% of all solid tumors have HER2 mutations. This makes it a potential target for treatm
Cancer is not just a physical battle. It also takes a toll on the mind and spirit. Many people with cancer find comfort in spirituality. But how can healthcare workers best support this need? A recent study looked at different ways to help cancer patients explore their spirituality. The study found
Cancer is a tricky foe, always finding ways to dodge treatments. One type, Ewing sarcoma, often affects young people. It's caused by a gene fusion called EWS::FLI1. This fusion acts like a commander, driving cancer cells to multiply uncontrollably. Scientists made a surprising find. EWS::FLI1 disru
Cancer is tricky. It hides and grows, making it hard to treat. But what if we could send tiny, smart helpers to find and fight cancer cells? That's the idea behind a new type of nanoparticle. These aren't just any nanoparticles. They're designed to stay calm and inactive while traveling through the
Cancer is a sneaky foe, but scientists are fighting back with clever tools. One such tool is a special kind of antibody designed to target multiple myeloma, a type of blood cancer. These antibodies are like smart missiles, programmed to seek out and attack cancer cells. Here's how they work: The an
Cancer treatment is expensive. Radiation therapy is a common treatment, but not everyone pays the same price. This is a big problem. Why does this happen? One reason is location. Where you live affects how much you pay. In some areas, radiation therapy costs more than in others. This is unfair, but
Cancer is a tough opponent. It's sneaky, hard to catch early, and even harder to treat. But scientists are always on the hunt for new ways to fight it. One exciting area of research is tiny bits of RNA called microRNAs. These little guys might hold the key to better cancer treatments and earlier det
Cancer doctors in France face a tricky situation. They often mix up research goals with patient care. This mix-up is called therapeutic misconception (TM). It happens when people in studies think the main goal is to help them, not to find out new things for everyone. Oncologists deal with this a lo
Cancer is a complex puzzle, with each type having its own set of rules. To crack this code, scientists need to understand how genes and the immune system interact. This is where TCGAimmunosurv comes in. It's a tool designed to make sense of vast amounts of data from cancer patients. This tool does
Cancer is a serious illness that requires strong weapons to fight. One powerful weapon is immune checkpoint inhibitors (ICIs). These treatments help the body's defense system attack cancer cells. They have been successful in helping people live longer, even when cancer has spread. However, these tre
